Key facts
- LifecellsNI’s last known valuation is $1.6M (Mar 2026).
- It has raised $800K; the latest was Seed Round ($800K) in Mar 2026.
- Notable investors include Founder Institute, Clarendon Fund Managers, AMP (Angel Syndicate), Amp Incubator.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for LifecellsNI
- ·The full record, as it builds
Funding rounds
No funding rounds for LifecellsNI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LifecellsNI
Operator of a stem cell biobank and cryogenic storage facility designed to provide safe preservation services and advanced laboratory rentals. The company offers cutting-edge stem cell extraction and storage for individuals and families, alongside GMP Grade A laboratory spaces and cryogenic storage solutions, enabling researchers, biotech companies, and clinical trials to conduct scientific innovation and preserve biological materials in a secure, compliant environment.
- Sector
- Healthcare
- HQ
- Londonderry, United Kingdom
- Founded
- 2022
- Employees
- 1
- Website
- mylifecells.net/
- Ownership
- Privately Held (backing)
LifecellsNI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LifecellsNI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LifecellsNI in its N-PORT filings yet. We sweep new filings monthly.